CoChat

Use of Metabolic Markers To Identify Overweight Individuals Who Are Insulin Resistant

The DOI matches its Crossref record; 41 of the 42 references it cites were found in a registry or an index.

Abstract

BACKGROUND: Insulin resistance is more common in overweight individuals and is associated with increased risk for type 2 diabetes mellitus and cardiovascular disease. Given the current epidemic of obesity and the fact that lifestyle interventions, such as weight loss and exercise, decrease insulin resistance, a relatively simple means to identify overweight individuals who are insulin resistant would be clinically useful. OBJECTIVE: To evaluate the ability of metabolic markers associated with insulin resistance and increased risk for cardiovascular disease to identify the subset of overweight individuals who are insulin resistant. DESIGN: Cross-sectional study. SETTING: General clinical research center. PATIENTS: 258 nondiabetic, overweight volunteers. MEASUREMENTS: Body mass index; fasting glucose, insulin, lipid and lipoprotein concentrations; and insulin-mediated glucose disposal as quantified by the steady-state plasma glucose concentration during the insulin suppression test. Overweight was defined as body mass index of 25 kg/m2 or greater, and insulin resistance was defined as being in the top tertile of steady-state plasma glucose concentrations. Receiver-operating characteristic curve analysis was used to identify the best markers of insulin resistance; optimal cut-points were identified and analyzed for predictive power. RESULTS: Plasma triglyceride concentration, ratio of triglyceride to high-density lipoprotein cholesterol concentrations, and insulin concentration were the most useful metabolic markers in identifying insulin-resistant individuals. The optimal cut-points were 1.47 mmol/L (130 mg/dL) for triglyceride, 1.8 in SI units (3.0 in traditional units) for the triglyceride-high-density lipoprotein cholesterol ratio, and 109 pmol/L for insulin. Respective sensitivity and specificity for these cut-points were 67%, 64%, and 57% and 71%, 68%, and 85%. Their ability to identify insulin-resistant individuals was similar to the ability of the criteria proposed by the Adult Treatment Panel III to diagnose the metabolic syndrome (sensitivity, 52%, and specificity, 85%). CONCLUSIONS: Three relatively simple metabolic markers can help identify overweight individuals who are sufficiently insulin resistant to be at increased risk for various adverse outcomes. In the absence of a standardized insulin assay, we suggest that the most practical approach to identify overweight individuals who are insulin resistant is to use the cut-points for either triglyceride concentration or the triglyceride-high-density lipoprotein cholesterol concentration ratio.

Overview

Integrity signals

Registry

Crossref · 10.7326/0003-4819-139-10-200311180-00007

Cites

41 of 41 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 41 references

Research works printed but not linked: 2

  1. 10.1210/jcem.83.8.5005 · doi:10.1210/jcem.83.8.5005 · Paper page
  2. McLaughlin T, 1999, J Clin Endocrinol Metab, 84, 578

Cited by

See all 1,022

Metadata

Authors
McLaughlin, T., Abbasi, F., Cheal, K., Chu, J., Lamendola, C., & Reaven, G.
Affiliations
Stanford Medicine (US)
Venue
Annals of Internal Medicine
Published
2003-11-18
Volume
139
Issue
10
Pages
802-809
ISSN
  • 0003-4819 (ISSN-L)
  • 1539-3704
OpenAlex
W1969831395
Cited by
1,022
References
42
Citations by year
2026: 33 · 2025: 34 · 2024: 41 · 2023: 30 · 2022: 52 · 2021: 47 · 2020: 36 · 2019: 50 · 2018: 39 · 2017: 38 · 2016: 39 · 2015: 43 · 2014: 47 · 2013: 50 · 2012: 54
FWCI
24.01
Type
journal article
Language
en
Open access
closed
Licence
www.acpjournals.org/journal/aim/text-and-data-mining (tdm)
Locations
  • Annals of Internal Medicine (publishedVersion)
  • PubMed (publishedVersion)
Funders
National Center for Research Resources (K23RR016071, RR-16071-01, RR000070-40, M01RR000070)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diet, Metabolism, and Disease
Keywords
insulin resistance, overweight, metabolic biomarkers, triglycerides, triglyceride to HDL cholesterol ratio, fasting insulin, insulin suppression test, metabolic syndrome, type 2 diabetes risk, cardiovascular risk, diagnostic thresholds
MeSH terms
Adult, Aged, Blood Glucose, Cardiovascular Diseases, Cholesterol, Cross-Sectional Studies, Diabetes Mellitus, Type 2, Female, Humans, Insulin, Insulin Resistance, Cholesterol, HDL, Male, Middle Aged, Obesity, Risk Factors, ROC Curve, Triglycerides, Biomarkers, Body Mass Index

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Use of Metabolic Markers To Identify Overweight Individuals Who Are Insulin Resistant. https://app.cochat.ai/papers/10.7326/0003-4819-139-10-200311180-00007
The paper
McLaughlin, T., Abbasi, F., Cheal, K., Chu, J., Lamendola, C., & Reaven, G. (2003). Use of Metabolic Markers To Identify Overweight Individuals Who Are Insulin Resistant. Annals of Internal Medicine. https://doi.org/10.7326/0003-4819-139-10-200311180-00007

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.